Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A

International Journal of Immunogenetics

Volumn 37, Issue 2, 2010, Pages 79-82

  Chaves, D ^a   Belisario A ^b   Castro, G ^b   Santoro, M ^a   Rodriguest, C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Serviço de Pesqu isa   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; INTERLEUKIN 10; PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; CYTOKINE PRODUCTION; DNA POLYMORPHISM; HAPLOTYPE; HEMOPHILIA A; HUMAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SUBSTITUTION THERAPY;

ADOLESCENT; ADULT; BLOOD COAGULATION FACTOR INHIBITORS; BRAZIL; CHILD; FACTOR VIII; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEMOPHILIA A; HUMANS; INTERLEUKIN-10; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 77953592167     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2009.00893.x     Document Type: Article

References (27)

1. Astermark, J., Oldenburg, J., Carlson, J., Pavlova, A., Kavakli, K., Berntorp, E. et al. (2006a) Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A. Blood, 108, 3739.
2. Astermark, J., Oldenburg, J., Pavlova, A., Berntorp, E. & Lefvert, A.K. & MIBS Study Group (2006b) Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A. Blood, 107, 3167.
3. Awad, M.R., Webber, S., Boyle, G., Sturchioc, C., Ahmed, M., Martell, J. et al. (2001) The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society of Heart Transplantation, 20, 625.
4. Aziz, T., Hasleton, P., Hann, A.W., Yonan, N., Deiraniya, A. & Hutchinson, I.V. (2000) Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation. The Journal of Thoracic and Cardiovascular Surgery, 119, 700.
5. Bathgate, A.J., Pravica, V., Perrey, C., Therapondos, G., Plevris, J.N., Hayes, P.C. et al. (2000) The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation, 69, 1514.
6. Bowen, D.J. & Keeney, S. (2003) Unleashing the long-distance PCR for detection of the intron 22 inversion of the factor VIII gene in severe haemophilia A. Thrombosis and Haemostasis, 89, 201.
7. Ehrenforth, S., Kreuz, W., Scharrer, I., Linde, R., Funk, M., Gungor, T. et al. (1992) Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet, 339, 594.
8. Eskdale, J., Wordsworth, P., Bowman, S., Field, M. & Gallagher, G. (1997) Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens, 49, 635.
9. Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphreis, S. et al. (1998) The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. The Journal of Clinical Investigation, 102, 1369.
10. Freidin, M.B., Kobyakova, O.S., Ogorodova, L.M. & Puzyrev, V.P. (2003) Association of polymorphisms in the human IL4 and IL5 genes with atopic bronchial asthma and severity of the disease. Comparative and Functional Genomics, 4, 346.
11. Hobbs, K., Negri, J., Klinnert, M., Rosenwasser, L.J. & Borish, L. (1998) Interleukin-10 and transforming growth factor-betpromoter polymorphisms in allergies and asthma. American Journal of Respiratory and Critical Care Medicine, 158, 1958.
12. Hoyer, L.W. (1987) Molecular pathology and immunology of factor VIII (hemophilia A and factor VIII inhibitors). Human Pathology, 18, 153.
13. Johnson, V.J., Yucesoy, B. & Luster, M.I. (2004) Genotyping of single nucleotide polymorphisms in cytokine genes using realtime PCR allelic discrimination technology. Cytokine, 27, 135.
14. Lazarus, M., Hajeer, A.H., Turner, D., Sinnott, P., Worthinhton, J., Olliver, W.E. et al. (1997) Genetic variation in the interleu-kin 10 gene promoter and systemic lupus erythematosus. The Journal of Rheumatology, 24, 2314.
15. Liu, Z., Colpaert, S., D'haens, G.R., Kasran, A., De Boer, M., Rutgeerts, P. et al. (1999) Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. Journal of Immunology, 163, 4049.
16. Moffatt, M.F. & Cookson, W.O. (1997) Tumour necrosis factor haplotypes and asthma. Human Molecular Genetics, 6, 551.
17. Myhr, K.M., Vagnes, K.S., Maroy, T.H., Aarseth, J.H., Nyland, H.I. & Vedeler, C.A. (2002) Interleukin-10 promoter polymorphisms in patients with multiple sclerosis. Journal of Neurological Science, 202, 93.
18. Nadel, S., Newport, M.J., Booy, R. & Levin, M. (1996) Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. The Journal of Infectious Disease, 174, 878.
19. Pravica, V., Asderakis, A., Perrey, C., Hajeer, A., Sinnott, P.J. & Hutchinson, I.V. (1999) In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. European Journal of Immunogenetics: Official Journal of the British Society of Histocompatibility and Immunogenetics, 26, 1.
20. Rood, M.J., Van Krugten, M.V., Zanelli, E., Van Der Linden, M.W., Keijsers, V., Schreuder, G.M. et al. (2000) TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis and Rheumatism, 43, 129.
21. Rosado, S., Rua-Figueroa, I., Vargas, J.A., Garcia-Laorden, M.I., Losada-Fernandez, I., Martin-Donaire, T. et al. (2008) Inter-leukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. International Journal of Immunogenetics, 35, 235.
22. Scassellati, C., Zanardini, R., Squitti, R., Bocchio-Chiavetto, L., Bonvicini, C., Binetti, G. et al. (2004) Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease. Neuro-science Letters, 356, 119.
23. Turner, D.M., Williams, D.M., Sankaran, D., Lazarus, M., Sinnot, P.J. & Hutchinson, I.V. (1997) Investigation of the polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics: Official Journal of the British Society of Histocompatibility and Immunogenetics, 24, 1.
24. Verbruggen, B., Novakova, I., Wessels, H., Boezeman, J., Van Den Berg, M. & Mauser-Bunschoten, E. (1995) The Nijmegen modification of Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thrombosis and Haemos-tasis, 73, 247.
25. Wergeland, S., Beiske, A., Nyland, H., Hovdal, H., Jensen, D., Larsen, J.P. et al. (2005) IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosis. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies, 12, 171.
26. Wilson, A.G., Di Giovine, F.S., Blakemore, A.I. & Duff, G.W. (1992) Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Human Molecular Genetics, 1, 353.
27. Wu, J.M., Bensen-Kennedy, D., Miura, Y., Thoburn, C.J., Armstrong, D., Vogelsang, G.B. et al. (2005) The effects of inter-leukin 10 and interferon cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer. Biology of Blood and Marrow Transplantation, 11, 455.